Report Summary 1. Reported Industry Investment Rating No relevant content provided. 2. Core Viewpoints of the Report - The adult incontinence products industry in China is at the end of the introduction period and the beginning of the explosion period, with a penetration rate of about 8%-10%, and there is still significant room for growth compared to international markets [19]. - The long - term care insurance (both TOG and TOC) is expected to promote the industry. The TOG part may lead to a penetration rate of up to 50% within 10 years, and the TOC part shows an increasing demand for brand - building [20][22]. - Reliable Co., Ltd. has made strategic adjustments in product and channel planning, aiming to become the absolute number one in the Chinese adult incontinence field [22]. - The price of adult incontinence products in China is in a state of chaos, and the price is expected to increase with the advancement of long - term care insurance and strengthened market supervision [23][24]. - The industry concentration is increasing, and domestic brands like Reliable have the potential to replicate the success of overseas leading brands [25]. - Although the company's business has been under short - term pressure, it has optimized profitability through cost reduction and efficiency improvement, and is expected to achieve significant growth in the next 3 years [26]. 3. Summary by Questions Question 1: Growth level and industry ceiling of the adult incontinence products industry - The industry in China is at the end of the introduction period and the beginning of the explosion period, with a penetration rate of 8% - 10%, while in Europe, America, and Japan, the penetration rates are 60% and 80% respectively [19]. - The potential of the medium - and mild - incontinence population has not been fully explored [19]. Question 2: The promoting effect of long - term care insurance on the industry - TOG: Referring to Japan's experience, China's long - term care insurance is expected to lead to a penetration rate of up to 50% within 10 years after national promotion [20]. - TOC: The current buyers are mainly relatives of the elderly, with a high proportion of online channels. There is an increasing demand for brand - building and user - service enhancement [22]. Question 3: Product and channel planning in the next three years - Channels: Shifted from dealer - and store - based sales to TOB business, entered hospitals and elderly care institutions, and established a user - operation department for online business [22]. - Brands: Launched the Anhu shi brand targeting cost - effective consumers, and strengthened the positions of Reliable and Xishoubao [22]. - TOG business: Seize government procurement opportunities including long - term care insurance [22]. - Supply chain: Invested in companies like Guangxi Hanggang three years ago to form a closed - loop supply chain [22]. Question 4: Price level and price - increasing potential - The price band in China is chaotic, including high - end, mid - high - end, mid - low - end, and ultra - low - end products. About 210 million pieces of sub - standard products were exposed in 315 this year, accounting for nearly 30% of the market [23]. - In Japan, there are only high - end and mid - high - end products. The price in China is expected to increase with the advancement of long - term care insurance and strengthened market supervision [24]. Question 5: Current competitive landscape and brand concentration - In Europe, America, and Japan, the market share of the first - ranked brand exceeds 50%. Reliable is the leading domestic brand and plans to expand overseas [25]. - The industry concentration is increasing, and domestic brands have the potential to follow the path of overseas leading brands [25]. Question 6: Company's profitability and future growth points - The company's business has been under short - term pressure due to factors such as a decrease in the elderly population and birth rate [26]. - Profitability has been optimized through cost reduction and efficiency improvement, and the optimization of the mother - and - baby segment [26]. - The company is expected to achieve significant growth in the next 3 years with the implementation of long - term care insurance policies, enhanced brand recognition, and overseas expansion [26].

Investment Rating - The report maintains a "Recommended" rating for the company with a target price of 16.1 CNY per share [2][8]. Core Views - The company has optimized its cost structure and accelerated the cultivation of its own brand, leading to significant profit growth. In 2024, the company achieved revenue of 1.08 billion CNY, a slight decrease of 0.3% year-on-year, while the net profit attributable to the parent company increased by 54.4% to 30 million CNY [2][4]. - The first quarter of 2025 showed a revenue of 280 million CNY, a decrease of 1.0% year-on-year, but the net profit attributable to the parent company increased by 1.4% to 20 million CNY [2][4]. Financial Summary - **2024 Financial Performance**: - Total revenue: 1,079 million CNY - Net profit attributable to the parent: 31 million CNY - Earnings per share: 0.11 CNY - Gross margin: 20.8%, up 3.1% year-on-year [4][9]. - **2025-2027 Projections**: - Expected revenue growth: 1,152 million CNY in 2025, 1,256 million CNY in 2026, and 1,393 million CNY in 2027, with year-on-year growth rates of 6.8%, 9.0%, and 10.9% respectively [4][9]. - Projected net profit attributable to the parent: 32 million CNY in 2025, 51 million CNY in 2026, and 68 million CNY in 2027, with growth rates of 3.5%, 59.6%, and 32.1% respectively [4][9]. - **Cost Structure**: - The company has improved its gross margin through increased procurement from joint ventures, leading to a gross margin of 24.3% in Q1 2025, up 3.9 percentage points year-on-year [2][4]. Product Performance - In 2024, the company’s product segments showed varied performance: - Adult incontinence products: Revenue of 558 million CNY, down 1.33% year-on-year - Baby care products: Revenue of 416 million CNY, up 6.82% year-on-year - Pet hygiene products: Revenue of 69 million CNY, down 22.48% year-on-year [2][8]. - The company launched several new products in 2024, generating nearly 40 million CNY in sales, indicating a focus on expanding its product matrix [2][8].

Investment Rating - The report maintains a "Recommended" rating for the company with a target price of 16.1 yuan per share [2][8]. Core Insights - The company reported a revenue of 1.08 billion yuan and a net profit attributable to shareholders of 30 million yuan for 2024, showing a slight revenue decline of 0.3% year-on-year but a significant net profit increase of 54.4% [2][4]. - In Q1 2025, the company achieved a revenue of 280 million yuan, with a net profit of 20 million yuan, reflecting a 1.0% decline in revenue but a 1.4% increase in net profit year-on-year [2][4]. - The company continues to optimize its cost structure and accelerate the cultivation of its own brand, with a focus on adult incontinence products, baby care, and pet hygiene products [2][8]. Financial Performance Summary - For 2024, the total revenue is projected to be 1,079 million yuan, with a year-on-year growth rate of -0.3%. The net profit is expected to reach 31 million yuan, with a growth rate of 54.4% [4][9]. - The company anticipates revenue growth of 6.8% in 2025, reaching 1,152 million yuan, and a net profit of 32 million yuan, with a growth rate of 3.5% [4][9]. - The gross margin for 2024 is reported at 20.8%, an increase of 3.1 percentage points year-on-year, attributed to improved cost structure [8][9]. Product and Market Development - The company has developed a range of new products, including specialized series for institutions and seasonal products, with new product sales expected to approach 40 million yuan in 2024 [8]. - During the Double Eleven shopping festival, the company's own brand adult diapers achieved an online GMV exceeding 70 million yuan, with a year-on-year growth of over 20% [8]. Future Projections - The company is expected to achieve net profits of 32 million yuan in 2025, 51 million yuan in 2026, and 68 million yuan in 2027, with corresponding P/E ratios of 127, 80, and 60 [8][9].

Market Overview - The adult incontinence products industry in China is at the end of the introduction phase and the beginning of the explosive growth phase, with a penetration rate of approximately 8%-10% [1] - Compared to international markets, where penetration rates reach 60% in Europe and the US, and 80% in Japan, there is significant growth potential in China [1] - The primary user group currently consists of individuals with severe incontinence, but there is untapped potential among those with moderate and mild incontinence [1] Policy Impact - The introduction of long-term care insurance (TOG and TOC) is expected to accelerate market expansion, with a projected penetration rate of 50% within 10 years following nationwide promotion after 2024 [1][2] - Historical data from Japan shows that after the implementation of care insurance, the penetration rate of adult diapers increased from 10% in 1990 to 80% in 2005 [1] Product and Channel Strategy - The company has shifted its sales strategy from relying on distributors and physical stores to focusing on B2B business, targeting hospitals and elderly care institutions, with over 10,000 institutions engaged [2] - Online channels are increasingly important, with a new brand targeting cost-conscious consumers launched on platforms like Pinduoduo, showing promising sales growth [2] - The company is enhancing user engagement through improved service offerings and targeted marketing strategies [2] Pricing and Market Dynamics - The adult diaper market in China is fragmented into four price segments: high-end, mid-high, mid-low, and ultra-low, with the ultra-low segment facing quality issues [3] - Approximately 21 billion low-quality diapers, accounting for nearly 30% of the market, have been identified, indicating a need for regulatory improvements [3] - Price increases are anticipated due to the push for long-term care insurance and stricter market regulations [3] Competitive Landscape - In mature markets like the US and Japan, leading brands hold over 50% market share, while the leading domestic brand in China, Reliable, is positioned to compete internationally [4] - The industry is experiencing a trend towards increased concentration, with local brands expected to replicate the success of overseas leaders [4] Financial Performance and Growth Outlook - The company faces short-term challenges due to demographic shifts, including a declining birth rate and aging population [6] - Cost optimization measures, such as the use of smart factories and alternative raw materials, are being implemented to enhance profitability [6] - Future growth is anticipated from the rollout of long-term care insurance, increased brand recognition, and international expansion [6]

Summary of Conference Call on Reliable Co. and Adult Incontinence Products Market Industry Overview - The adult incontinence products market in China has significant potential, with a current penetration rate below 10%, compared to 60% in Europe and the US, and 80% in Japan. The market is expected to grow to around 50% over the next decade due to aging population and the nationwide promotion of long-term care insurance starting in 2025 [2][3][5]. Key Points and Arguments - **Long-term Care Insurance Impact**: The introduction of long-term care insurance is a crucial factor for market growth. Japan's experience shows that such insurance can significantly increase market penetration from 10% to 60% over 15 years. China's government plans to implement this insurance nationwide, which is expected to positively impact the adult incontinence products market [2][4][5]. - **Reliable Co.'s Market Position**: Reliable Co. is positioned as a market leader, leveraging brand development and channel strategies, particularly excelling in e-commerce. The company has made strategic adjustments in channel transformation, user operations, and digital marketing, which have shown growth effects in the 2024 annual report [2][6][11]. - **Consumer Behavior**: The market features a separation between users and purchasers, with online channels being significant. Consumers demand high quality, and brand recognition is gradually increasing. Membership user operations can enhance customer loyalty [2][8]. - **Market Pricing Dynamics**: The adult diaper market in China is characterized by chaotic pricing with many low-quality products. The promotion of long-term care insurance and market standardization is expected to phase out low-end products, leading to a shift towards quality and branding [2][12][13]. Additional Important Insights - **Strategic Planning**: Reliable Co.'s strategic planning for the next three years includes adapting to post-pandemic consumer behavior, channel transformation towards direct services, user operations to attract new customers, and increased digital marketing efforts [9][10]. - **Competitive Advantage**: Reliable Co. holds a competitive edge in government procurement and long-term care insurance sectors, supported by strategic supply chain investments. The company aims to become the absolute leader in the down-market segment [4][11]. - **Challenges for SMEs**: As the industry standardizes, small and medium enterprises may face challenges due to strict quality regulations, which could lead to market exit for those unable to meet standards [14]. - **International Expansion Plans**: Reliable Co. plans to expand internationally, targeting developed countries for adult incontinence products and developing countries for baby diapers and sanitary pads, leveraging its competitive product quality and flexible manufacturing capabilities [17]. - **Profitability Outlook**: After a period of low profitability due to various factors, the company anticipates significant growth in sales and profits over the next three years, driven by improved operational efficiency and cost control measures [18][19].

截至5月20日收盘，宠物经济概念上涨4.08%，位居概念板块涨幅第2，板块内，83股上涨，天元宠物、 创源股份等20%涨停，贝因美、依依股份、实丰文化等涨停，路斯股份、驱动力、美农生物等涨幅居 前，分别上涨18.10%、14.10%、13.81%。跌幅居前的有哈三联、新华制药、狮头股份等，分别下跌 3.49%、3.23%、3.01%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 培育钻石 | 4.10 | 航运概念 | -1.44 | | 宠物经济 | 4.08 | 中韩自贸区 | -1.24 | | 动物疫苗 | 4.00 | 成飞概念 | -1.16 | | 重组蛋白 | 3.90 | PEEK材料 | -0.75 | | IP经济(谷子经济) | 3.45 | 自由贸易港 | -0.68 | | 人造肉 | 3.14 | 钛白粉概念 | -0.58 | | 托育服务 | 2.95 | 碳纤维 | -0.34 | | 兵装重组概念 | 2.75 | 太赫兹 | -0.23 | | NFT概念 | 2. ...

Market Overview - The Shanghai Composite Index rose by 0.38% on May 20, with 27 out of the 28 sectors experiencing gains, led by the beauty and personal care sector, which increased by 2.50% [2] - The defense and military industry and coal sector were the only sectors to decline, with decreases of 0.50% and 0.33% respectively [2] Capital Flow Analysis - The main capital flow showed a net outflow of 1.037 billion yuan across the two markets, with 18 sectors seeing net inflows [2] - The electronics sector had the highest net inflow, amounting to 2.673 billion yuan, and it rose by 0.71% [2] - The pharmaceutical and biotechnology sector also performed well, with a daily increase of 1.64% and a net inflow of 1.555 billion yuan [2] Beauty and Personal Care Sector - The beauty and personal care sector saw a daily increase of 2.50%, with a net inflow of 268 million yuan [3] - Out of 31 stocks in this sector, 24 stocks rose, including 2 that hit the daily limit, while 6 stocks declined [3] - The top three stocks by net inflow were: - Reliable Co., with a net inflow of 115 million yuan and a price increase of 12.14% [3] - Yiyi Co., with a net inflow of 101 million yuan and a price increase of 10.02% [3] - Aimeike, with a net inflow of 78.9 million yuan and a price increase of 3.93% [3] Notable Stocks in Beauty and Personal Care Sector - The following stocks had significant capital flows: - Reliable Co. (12.14% increase, 31.85% turnover, 114.57 million yuan inflow) [4] - Yiyi Co. (10.02% increase, 17.90% turnover, 100.68 million yuan inflow) [4] - Aimeike (3.93% increase, 2.81% turnover, 78.90 million yuan inflow) [4] - Conversely, the stocks with the highest net outflows included: - Qingdao King (5.23% decrease, 27.12% turnover, 162.54 million yuan outflow) [4] - Qingsong Co. (1.50% decrease, 24.11% turnover, 54.19 million yuan outflow) [4] - Fulejia (10.77% increase, 16.50% turnover, 20.36 million yuan outflow) [4]

Group 1: Financial Performance - In 2024, the company's revenue slightly decreased by 0.27%, while net profit increased by 54.44% due to cost control and product structure optimization [6] - The gross profit margin improved by 3.14 percentage points to 20.79% [8] - The company reported a credit impairment loss of 3.1068 million and inventory impairment loss of 12.3583 million in 2024 [4] Group 2: Market Strategies - The company achieved an online GMV exceeding 70 million yuan in 2024, with a year-on-year growth of over 20% [1] - In the Shanghai region, sales growth reached 58% through targeted channel management [3] - The company’s offline special channel business revenue grew by 58% in 2024, primarily from hospital surrounding stores and long-term care insurance projects [4] Group 3: Product Development and Innovation - The "Absorbent Treasure 2.0" series received positive market feedback, with some items achieving monthly sales exceeding classic models by 50% [2] - The high-absorption composite core technology has been applied in the production of baby and adult diapers, enhancing product differentiation [4] - The company’s investment in smart manufacturing has led to significant improvements in logistics efficiency and production control [2] Group 4: R&D and Future Plans - R&D investments in 2024 focused on high-absorption composite core technology and other patented technologies [3] - The company plans to expand its ODM business, which saw a revenue decline of 21.8% in 2024, by acquiring new domestic and international clients [5] - The company has initiated a cross-border e-commerce strategy, with overseas sales expected to grow significantly [10] Group 5: Corporate Governance and Investor Relations - The management's high compensation is deemed reasonable compared to industry peers, with a commitment to long-term growth in the aging economy sector [6] - The company implemented a cash dividend policy, distributing 99.77% of 2023 net profit and planning to distribute 59.83% of 2024 net profit [11] - A share buyback plan was initiated in 2024, completing the repurchase of 5,435,800 shares, accounting for 2.00% of the total share capital [11]

证券代码：301009 证券简称：可靠股份 公告编号：2025-019 杭州可靠护理用品股份有限公司 关于参加 2025 年浙江辖区上市公司投资者网上集体 接待日暨 2024 年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，杭州可靠护理用品股份有限公司（以下 简称"公司"）将参加由浙江证监局指导，浙江上市公司协会主办，深圳市全景 网络有限公司承办的"2025年浙江辖区上市公司投资者网上集体接待日暨2024年 度业绩说明会"，现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （https://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演APP， 参与本次互动交流，活动时间为2025年5月13日（周二）15:00-17:00。届时，公 司董事长、总经理兼董事会秘书（代行）金利伟先生，副总经理兼财务总监李超 楠女士，独立董事肖炜麟先生，保荐代表人庞燎源先生将在线就公司2024年度业 绩、公司治理、发展战略、经营状况、融资计划、股权激励和可持续发展等投资 ...

Investment Rating - The investment rating for the company is "Buy" with a target price not specified [5] Core Views - The company is leveraging both its proprietary brand and ODM (Original Design Manufacturer) model to drive growth and expand into new markets and product categories [2] - The company is focusing on upgrading its product offerings, particularly in the adult incontinence segment, to cater to a broader demographic, including elderly and postpartum women [2] - The company aims to enhance its user engagement through a refined user operation system that integrates products and services, utilizing AI for customer support [3] - The financial forecasts have been adjusted, with expected revenues of 1.14 billion, 1.22 billion, and 1.35 billion for 2025, 2026, and 2027 respectively, alongside net profits of 0.34 billion, 0.37 billion, and 0.42 billion for the same years [4] Financial Performance Summary - In Q1 2025, the company reported revenue of 300 million, a decrease of 1% year-on-year, while net profit attributable to the parent company was 20 million, an increase of 1.4% [1] - For the year 2024, the company anticipates a revenue of 1.1 billion, a decrease of 0.3%, and a net profit of 30 million, an increase of 54% [1] - The breakdown of revenue by product for 2024 includes adult incontinence products at 560 million (down 1%), baby products at 400 million (up 7%), and pet hygiene products at 70 million (down 22%) [1] - The company’s gross margin for adult incontinence products is projected to be 19.4%, for baby products 21%, and for pet hygiene products 22% [1] Market and Product Strategy - The company is set to launch a new medical-grade cranberry probiotic absorbent pad by March 2025, aimed at addressing user pain points related to absorption and health [2] - The strategy includes developing welfare products tailored to specific user needs and enhancing product differentiation across various market segments [2] - The company is also focusing on building a valuable user operation system that enhances brand engagement through various outreach methods, including online platforms and community initiatives [3]